WuXi Accepts $3.3 Billion Go-Private Offer

WuXi PharmaTech, China's largest CRO/CMO, formally accepted the $3.3 billion ($46 per ADS) merger offer that will take the company private. The company expects the merger, which must still be voted on by shareholders, to close in Q4. The investors backing the offer include Ally Bridge Group, Boyu Capital, Temasek Life Sciences, Ping An Insurance and Hillhouse Fund. Shanghai Pudong Development Bank and Ping An Bank will lead a syndicate to raise $1.1 billion in debt financing. More details.... Stock Symbol: (NYSE: WX) Share this with colleagues: // //